-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SYEeMeQIeQbNCkSua8tVQz/+CEdLsXSsC6rvxCDo6h1Z5NMTNA33+KcReD5Tsb6I 97yPXnNAIa1O3Lq16R23FQ== 0000897101-06-001190.txt : 20060602 0000897101-06-001190.hdr.sgml : 20060602 20060601184036 ACCESSION NUMBER: 0000897101-06-001190 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060601 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20060602 DATE AS OF CHANGE: 20060601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ST JUDE MEDICAL INC CENTRAL INDEX KEY: 0000203077 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411276891 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12441 FILM NUMBER: 06881108 BUSINESS ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 BUSINESS PHONE: 6514832000 MAIL ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 8-K 1 stjude062306_8k.htm FORM 8-K DATED JUNE 1, 2006 St. Jude Medical, Inc. Form 8-K dated June 1, 2006

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 1, 2006

ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota	0-8672	41-1276891
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

One Lillehei Plaza, St. Paul, MN	55117
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

St. Jude Medical, Inc. (the “Company”) has completed the repurchase of shares of its common stock under its previously announced $700 million share repurchase authorization. The following table provides information about the shares repurchased by the Company under the share repurchase authorization:

Period

4/02/06 – 4/29/06	4,847,000	$ 39.52	4,847,000	$508,455,000

4/30/06 – 5/26/06	13,732,390	$ 37.03	13,732,390	$ 0

	18,579,390	$ 37.68	18,579,390	$ 0

⁽¹⁾

On April 19, 2006, the Company announced that its Board of Directors had authorized a new share repurchase program of up to $700 million of the Company’s outstanding common stock. On April 21, 2006, the Company began making share repurchases through transactions in the open market in accordance with applicable securities laws. The repurchase plan entered into by the Company under the repurchase authorization terminated on May 26, 2006, the date on which no further purchases were authorized under the plan.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		ST. JUDE MEDICAL, INC.


Date:	June 1, 2006	By:	/s/ Kevin T. O’Malley
			Kevin T. O’Malley
			Vice President and General Counsel

-----END PRIVACY-ENHANCED MESSAGE-----